IDH2 and chondrosarcoma: IDH mutations have been also identified in enchondromas, considered as benign precursor lesions of chondrosarcomas [128]; this finding suggests that IDH mutations are early genetic events in the process of carcinogenesis in the chondrogenic lineage [129].